A Randomized, Multicenter, Phase II study to Investigate Efficacy and Safety of ITF2984 in Acromegalic patients.

Trial Profile

A Randomized, Multicenter, Phase II study to Investigate Efficacy and Safety of ITF2984 in Acromegalic patients.

Completed
Phase of Trial: Phase II

Latest Information Update: 19 May 2017

At a glance

  • Drugs Somatostatin (Primary) ; Octreotide
  • Indications Acromegaly
  • Focus Therapeutic Use
  • Acronyms POC
  • Sponsors Italfarmaco
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 15 Jun 2016 Status changed from active, no longer recruiting to completed.
    • 31 May 2016 The trial was completed in Italy (end date:2016-02-08).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top